CD8 + T cells in Flt3L+NDV-treated compared with untreated, Flt3L- or NDV-treated tumors, it did not reach statistical significance (Supplementary Fig. 6f ).
← all excerpts
Expanding cross-presenting dendritic cells enhances oncolytic virotherapy and is critical for long-term anti-tumor immunity.
1
—
—